Alport Foundation of Australia
 
ALPORT FOUNDATION OF AUSTRALIA
RESEARCH GRANTS

 

2010


$20,000

Melbourne University/Prof J Savige


Novel Chemical Treatments for Alport Syndrome


$20,000

Monash University/AProf Sharon Ricardo


Novel stem cell assays for Alports Syndrome



2011


$20,000

Melbourne University/Prof J Savige


Examining the effect of chemical chaperones in mice with X-linked and autosomal recessive Alport syndrome


$20,000

Melbourne University/Prof J Savige


Enlarging the LOVD COL4A3/COL4A4 Databases for autosomal Alport syndrome to improve diagnostic accuracy and predict renal failure



2012


$20,000

Monash University/AProf Sharon Ricardo


Kidney Stem Cell Lines for Alport syndrome


$5,000

Griffiths University/Dr Madeleine Peterson


Optimising genetic counseling support for individuals and families affected by Alport syndrome


$20,000

Melbourne University/Prof J Savige


Effect of COL4A5 mutations in induced pluripotent stem cells from X-linked Alport Syndrome – an in vitro model for evaluating new therapies



2013


$20,000

Monash University/Dr John Haynes & Prof Sharon Ricardo


Using induced pluripotent stem cell-derived podocytes to create an in vitro model of Alport Syndrome



2014


$20,000

Melbourne University/Prof J Savige


Correcting the mutation defect in Alport syndrome in human cell lines using the TALEN method: a potentially-curative treatment


$7,000

Royal Brisbane Womens Hospital/Dr Andrew Mallett


Next Generation Sequencing and Induced Pluripotent Stem Cell Applications in Genetic Renal Disease (Alport Syndrome Cohort)


$13,000

Childrens Hospital Westmead/AProf Steve Alexander

(associate of above)

University of Queensland/Prof Melissa Little

(associate of above)


$20,000

Melbourne University/Prof J Savige


Development of the Alport Foundation of Australia Patient Registry



2015


$20,000

Melbourne University/Prof J Savige


A clinical trial of a chemical chaperone, PBA, in X-linked Alport syndrome due to missense mutations


$20,000

Monash University/AProf Sharon Ricardo


Fate mapping kidney podocytes



2016



$17,360

Monash University/Dr John Haynes & Prof Sharon Ricardo


Dysregulation of focal adhesion kinase in Alport Syndrome patients


$20,000

Monash University/Profs Ricardo & Smyth


Generation of X-linked rodent models of Alport syndrome using CRISPR/Casmediated genome engineering


$15,000

Dr Hugh McCarthy


Utilising Whole Genome Sequencing to identify novel pathogenic mutations in patients with a clinical diagnosis of Alport Syndrome



 

David Blatt

Chairman

Alport Foundation of Australia

THE ALPORT FOUNDATION OF AUSTRALIA HAS DONATED $300,000 TO AUSTRALIAN RESEARCHERS